The latest news from oncology events around the world
COSA 2023: Fertility preservation and cancer
Having a baby is a realistic aspiration for young women undergoing cancer treatment but fertility…
Browsing: News
ESMO 2023: Amivantamab plus chemo with or without lazertinib reduced risk of disease progression or death for EGFR-mutated NSCLC
The results from the Phase 3 MARIPOSA-2 study have been announced showing the regimen of…
ESMO 2023: Highlights on sotorasib plus panitumumab in KRAS G12C-mutated mCRC: The CodeBreak 300 study
ESMO 2023: Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery…
ESMO 2023: Better use of existing drugs increases cervical cancer survival and reduces recurrence
The INTERLACE phase III trial, funded by Cancer Research UK and UCL Cancer Trials Centre,…
ESMO 2023: Highest risk patients with clear-cell renal cell carcinoma benefit from adjuvant everolimus
A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup…
ESMO 2023: Adding immunotherapy to chemotherapy regimen improves survival in metastatic bladder cancer patients
A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy…
ESMO 2023: Kidney cancer study shows improved outcomes for patients with advanced disease when treated with belzutifan over everolimus
Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the…
EADV Congress 2023: Non-melanoma skin cancer killing more people than melanoma, new study finds
Non-melanoma skin cancer (NMSC) is causing a greater number of global deaths than melanoma, the…
ASTRO 2023: Sexual activity and vaginal dilation associated with fewer side effects after cervical cancer treatment
People who engage in sexual activity or vaginal dilation after chemoradiation treatment for cervical cancer…